Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1159/000337273. Epub 2012 Apr 19.
Affiliations
- PMID: 22517315
- DOI: 10.1159/000337273
Randomized Controlled Trial
Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man
Aurélie P Weerts et al. Audiol Neurootol. 2012.
Abstract
Introduction: Sensory conflicts in the vestibular system lead to motion sickness of which space motion sickness (SMS) is a special case. SMS affects up to 70% of the astronauts during the first 3 days in space. The search for effective countermeasures has led to several nonpharmacological and pharmacological approaches. The current study focuses on the effects of lorazepam (1 mg), meclizine (25 mg), promethazine (25 mg), and scopolamine (0.4 mg) on the vestibular system, with special focus on the canal and otolith functions separately.
Methods: The study had a placebo-controlled, single blind, repeated measures design. Sixteen healthy volunteers were subjected to a total of 7 test sessions, the first and last being without intake of medication. Semicircular canal function was evaluated by means of electronystagmography and otolith function with unilateral centrifugation. The horizontal semicircular canal function was characterized by the vestibulo-ocular reflex (VOR) gain measured during earth vertical axis rotation as well as the total caloric response. The function of the utricles was represented by the utricular sensitivity, reflecting the ocular counter roll relative to the virtual induced head tilt.
Results: Promethazine significantly decreased the semicircular canal and utricular parameters. Both scopolamine and lorazepam caused only a decrease in the utricular sensitivity, whereas meclizine only decreased the semicircular canal-induced VOR gain.
Discussion: The results show that the drugs affected different areas of the vestibular system and that the effects can thus be attributed to the specific pharmacological properties of each drug. Meclizine, as an antihistaminergic and weak anticholinergic drug, only affected the VOR gain, suggesting a central action on the medial vestibular nucleus. The same site of action is suggested for the anticholinergic scopolamine since acetylcholine receptors are present and utricular fibers terminate here. The global vestibular suppression caused by promethazine is probably a consequence of its anticholinergic, antihistaminergic, and antidopaminergic properties. Based on the fact that lorazepam increased the affinity of gamma-aminobutyric acid (GABA) for the GABA(A)-receptor and its effects on the utriculi, the site of action seems to be the lateral vestibular nucleus.
Conclusion: Meclizine, scopolamine, and lorazepam selectively suppress specific parts of the vestibular system. Selective suppression of different parts of the vestibular system may be more beneficial for alleviating (space) motion sickness than general suppressive agents. Additionally, this knowledge may help the clinician in his therapeutic management of patients with either semicircular canal or otolith dysfunction.
Copyright © 2012 S. Karger AG, Basel.
Similar articles
- Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
Dornhoffer J, Chelonis JJ, Blake D. Dornhoffer J, et al. Otol Neurotol. 2004 Sep;25(5):740-5. doi: 10.1097/00129492-200409000-00016. Otol Neurotol. 2004. PMID: 15354005 Clinical Trial. - Intranasal scopolamine affects the semicircular canals centrally and peripherally.
Weerts AP, Putcha L, Hoag SW, Hallgren E, Van Ombergen A, Van de Heyning PH, Wuyts FL. Weerts AP, et al. J Appl Physiol (1985). 2015 Aug 1;119(3):213-8. doi: 10.1152/japplphysiol.00149.2015. Epub 2015 May 7. J Appl Physiol (1985). 2015. PMID: 25953832 Clinical Trial. - Effects of drug countermeasures for space motion sickness on working memory in humans.
Paule MG, Chelonis JJ, Blake DJ, Dornhoffer JL. Paule MG, et al. Neurotoxicol Teratol. 2004 Nov-Dec;26(6):825-37. doi: 10.1016/j.ntt.2004.07.002. Neurotoxicol Teratol. 2004. PMID: 15451046 Clinical Trial. - Perspectives for the comprehensive examination of semicircular canal and otolith function.
Clarke AH. Clarke AH. Biol Sci Space. 2001 Dec;15(4):393-400. doi: 10.2187/bss.15.393. Biol Sci Space. 2001. PMID: 12101365 Review. - [Exploration of the otolith function].
Toupet M. Toupet M. Rev Laryngol Otol Rhinol (Bord). 2005;126(4):209-15. Rev Laryngol Otol Rhinol (Bord). 2005. PMID: 16496546 Review. French.
Cited by
- A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study.
Heuser F, Schulz CM, Hapfelmeier A, Lehnen N, Kochs EF, Wagner KJ. Heuser F, et al. BMC Anesthesiol. 2016 Oct 10;16(1):90. doi: 10.1186/s12871-016-0263-5. BMC Anesthesiol. 2016. PMID: 27724859 Free PMC article. Clinical Trial. - Pharmacological and non-pharmacological countermeasures to Space Motion Sickness: a systematic review.
Khalid A, Prusty PP, Arshad I, Gustafson HE, Jalaly I, Nockels K, Bentley BL, Goel R, Ferrè ER. Khalid A, et al. Front Neural Circuits. 2023 Jun 16;17:1150233. doi: 10.3389/fncir.2023.1150233. eCollection 2023. Front Neural Circuits. 2023. PMID: 37396400 Free PMC article. - The Impact of Oral Promethazine on Human Whole-Body Motion Perceptual Thresholds.
Diaz-Artiles A, Priesol AJ, Clark TK, Sherwood DP, Oman CM, Young LR, Karmali F. Diaz-Artiles A, et al. J Assoc Res Otolaryngol. 2017 Aug;18(4):581-590. doi: 10.1007/s10162-017-0622-z. Epub 2017 Apr 24. J Assoc Res Otolaryngol. 2017. PMID: 28439720 Free PMC article. - Idiopathic Labyrinthitis: Symptoms, Clinical Characteristics, and Prognosis.
Oussoren FK, Schermer TR, Bruintjes TD, Leeuwen RBV. Oussoren FK, et al. J Int Adv Otol. 2023 Nov;19(6):478-484. doi: 10.5152/iao.2023.231096. J Int Adv Otol. 2023. PMID: 38088320 Free PMC article. - The effects of meclizine on motion sickness revisited.
Wibble T, Engström J, Verrecchia L, Pansell T. Wibble T, et al. Br J Clin Pharmacol. 2020 Aug;86(8):1510-1518. doi: 10.1111/bcp.14257. Epub 2020 Mar 3. Br J Clin Pharmacol. 2020. PMID: 32077140 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources